FDA has authorized the Invitae Common Hereditary Cancers Panel, a blood test that detects inherited genetic changes that increase the risk of some cancers.
FDA Authorizes Blood Test for Hereditary Cancer Risk
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
FDA has authorized the Invitae Common Hereditary Cancers Panel, a blood test that detects inherited genetic changes that increase the risk of some cancers.